
CLBT Stock Forecast & Price Target
CLBT Analyst Ratings
Bulls say
Cellebrite DI is poised for continued success, with a solid financial performance and a strong focus on expansion and innovation. However, potential risks and challenges must be carefully monitored to ensure sustained growth. Their success will also depend on their ability to effectively capitalize on cross-selling and upselling opportunities to existing customers. The pending acquisition of Corellium also presents potential for further growth and diversification in their offerings.
Bears say
Cellebrite DI is a purpose-built DI platform that is facing an intense market with many competitors, and any increase in competition could result in pricing pressure and market share loss. Additionally, the company also faces the risk of perception as a violation of privacy rights or human rights, which could impact its market opportunity. Other risks include fluctuations in foreign currency, extended sales cycles, and the potential for a breach of its solutions and data. Despite success in ARR and adjusted EBITDA in the past quarter, the company may still face challenges in meeting its margin outlook and could be impacted by a stock market correction.
This aggregate rating is based on analysts' research of Cellebrite DI Ltd and is not a guaranteed prediction by Public.com or investment advice.
CLBT Analyst Forecast & Price Prediction
Start investing in CLBT
Order type
Buy in
Order amount
Est. shares
0 shares